Menstruation Clinical Trials
A listing of Menstruation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 9 clinical trials
Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer
The primary objective of this study is to evaluate the safety and tolerability of BGT007H cell therapy in patients with recurrent/refractory pancreatic cancer.
- 0 views
- 13 May, 2025
- 1 location
- Online study
Auricular Acupressure for Premenstrual Syndrome in Female Students
physical disturbances occurring approximately one week before menstruation. PMS is especially prevalent among female undergraduate students, who often experience heightened stress due to academic pressures
- 0 views
- 20 May, 2025
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
an APG777 Parent Study (NCT06395948).The LTE study will consist of 3 periods: 1) Screening Visit will coincide with the last visit of the Maintenance Period in the Parent Study 2) Extended
- 0 views
- 15 Jul, 2025
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
is to compare the safety profile of ShA9 to placebo (vehicle) over 14 weeks of application, which includes an initial two-week period of co-treatment with topical corticosteroids (TCS). The primary
- 0 views
- 08 Jul, 2025
- 7 locations
VTP-1000 in Adults with Celiac Disease
placebo in a single ascending dose (SAD) and multiple ascending dose (MAD) format. Participants will be followed for a short period of time to assess the impact of VTP-1000 on their immune system (Adverse
- 0 views
- 12 Jun, 2025
Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma
to, and following the BBM-period. Data on efficacy and safety data will be collected through systematic analysis of electronic medical records and from the Swedish Cancer Registry.
- 0 views
- 24 Jun, 2025
Effect of Semaglutide in Patients With Psoriasis and Obesity (SEMPSO)
period, and a 12-week safety follow up period after the last study dose of semaglutide at week 24.
- 0 views
- 13 May, 2025
- 7 locations
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID-19.
- 0 views
- 23 May, 2025
- 22 locations
A Phase 3 Randomized, Open-label, Multicenter Study of Isatuximab (SAR650984) in Combination With Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With High-risk Smoldering Multiple Myeloma
Primary Objectives: Safety run-in: To confirm the recommended dose of isatuximab when combined with lenalidomide and dexamethasone in participants with high-risk smoldering multiple myeloma (SMM) Randomized Phase 3: To demonstrate the clinical benefit of isatuximab in combination with lenalidomide and dexamethasone in the prolongation of progression-free survival when compared to …
- 0 views
- 03 Jul, 2025
- 9 locations